Theravance Biopharma
TBPH
TBPH
91 hedge funds and large institutions have $533M invested in Theravance Biopharma in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
23% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 35
26% less capital invested
Capital invested by funds: $722M → $533M (-$189M)
Holders
91
Holding in Top 10
2
Calls
$478K
Puts
$236K
Top Buyers
| 1 | +$21.3M | |
| 2 | +$11.9M | |
| 3 | +$9.14M | |
| 4 |
D.E. Shaw & Co
New York
|
+$5.74M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.56M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$11.7M | |
| 3 | -$5.66M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.39M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.85M |